[1]
M. Tavakoli, E. Pirayesh, S. Khoshbakht, P. Javan Shayani, M. A. Ghodsi Rad, and M. Amoui, “Assessment of Neuroendocrine Features Using 99mTc-Octreotide Scintigraphy in Patients with Metastatic Castration-Resistant Prostate Cancer: Does it Predict Response to 177Lu-PSMA Radioligand Therapy?”, Urol J, vol. 23, no. 03, pp. 100–106, Aug. 2026.